Iceland boss calls for profit cap on energy firms as prices surge March 22, 2026 Richard Walker has urged the government to consider imposing a temporary cap on energy company profits, warning that households risk bearing the brunt of another price shock linked to the Middle East conflict. The Iceland boss, recently appointed as a Labour peer and cost of living adviser, said ministers should examine limiting earnings for producers [...]
CMA must act now to fix Britain’s broken cloud market March 20, 2026 The CMA correctly diagnosed the UK cloud market as broken and dysfunctional, so why isn’t it changing anything, writes Lord Clement-Jones.
Zopa Bank’s profit booms despite ‘penalised’ motor finance hit March 19, 2026 Zopa Bank cruised to its third consecutive year of profitability in 2025 but has offered a stark warning it feels “penalised” by the UK’s financial watchdog after getting swept up in the motor finance scandal. The Canary Wharf fintech has set aside £7.9m in provisions for the car mis-selling saga, which centres around the use [...]
City AM Awards 2026: Meet the Finalists March 18, 2026 And the nominees are…. Personality of the Year Greg Jackson CBE The entrepreneur and CEO of Octopus Energy has become one of the UK’s most prominent business leaders, known for his straight talking and punchy views across a range of topics including UK entrepreneurship, the business environment, capital markets and, of course, energy. In August [...]
ReNew Secures $95 Million Equity Investment From LeapFrog-Led Consortium to Expand its Commercial & Industrial Platform March 16, 2026 LeapFrog leads with $50 million, joined by co‑investors Emerging Market Climate Action Fund (“EMCAF”) and Carlyle AlpInvest ReNew has one of the largest clean energy portfolios for corporate customers in India
Labour told to scrap ‘arbitrary’ inheritance tax system March 15, 2026 The UK government is being urged to scrap the inheritance tax system following warnings that that it enforces the UK as a “high-tax outlier” and risks stifling investment and driving entrepreneurs abroad. A new report from the Institute of Economic Affairs (IEA) highlights that nearly half of the 38 OECD countries – where members are [...]
Miliband and Reeves to meet petrol retailers as fuel costs spike March 13, 2026 Energy Secretary Ed Miliband has said the government “will not tolerate” energy firms profiteering from the rising price of oil amid the war in Iran. Oil prices climbed back above $100 a barrel on Thursday despite the International Energy Agency (IEA) saying on Wednesday that it would release a record 400 million barrels of oil [...]
Richmond council to consider Lime’s future in contract vote March 12, 2026 Richmond councillors will next week decide whether to force Lime out of the borough’s booming e-bike market, City AM understands, as riders are mobilised ahead of a crunch committee meeting that could reshape cycling across southwest London. Emails seen by City AM show Lime users have been invited to attend Monday evening’s transport and air [...]
Here comes Elon: Tesla wins licence to supply electricity in Britain March 12, 2026 Tesla has been granted approval to supply electricity to homes and businesses across the UK, opening the door for the electric vehicle giant to enter the country’s retail energy market. Energy regulator Ofgem confirmed on Thursday that Tesla Energy Ventures Limited, a subsidiary of Musk’s company, has been granted an electricity supply licence by the [...]
Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan March 11, 2026 Japan is one of the world's most important pharmaceutical markets after the US and Europe. Neupharma’s team has extensive experience in developing and successfully commercialising orphan drugs as well as speciality care medicines in Japan, including a blockbuster drug. The agreement with Neupharma includes upfront and milestone payments of up to CHF 83.5 million as well as royalties of up to 20% on sales. The population of available patients eligible for corticorelin treatment associated with peritumoral brain edema is estimated at 60,000 in Japan and 500,000 worldwide. Global market potential is forecasted to exceed USD 1 billion annually.